Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Editorial
Review Article
View/Download PDF

Translate this page into:

Editorial
2022
:1;
1
doi:
10.25259/AJPPS_8_2021

Welcome to the American Journal of Pharmacotherapy and Pharmaceutical Sciences

City University of New York School of Medicine, New York, United States
Food and Drug Administration, Silver Spring, Maryland, United States
Clintriad Inc., West Chester, Pennsylvania, United States
Corresponding Author: Ashiwel S. Undieh, PhD City University of New York School of Medicine, New York, United States. ashiwel.undieh@ajpps.org
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Undieh AS, Nwakama P, Ikeme A. Welcome to the American Journal of Pharmacotherapy and Pharmaceutical Sciences. Am J Pharmacother Pharm Sci. 2022;1.

The launch of the American Journal of Pharmacotherapy and Pharmaceutical Sciences (AJPPS) signals a timely innovation in scientific publishing. Sponsored by the Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA) Inc., AJPPS was launched to fill a significant unmet need in scientific and professional publishing, namely, ongoing transdisciplinary integration of pharmaceutical science and practice. Members of NAPPSA can be found pursuing careers ranging from pharmacy practice, regulatory affairs, and drug manufacturing to academia and pharmaceutical research. The mission of AJPPS is to provide an integrated intellectual forum for the exchange of professional ideas and progress across the diverse pathways within, and emanating from, the pharmacy profession. This will be aided by the melding of articles that seek to translate pharmaceutical science into practice in juxtaposition with papers that communicate practice needs and experiences to guide scientific inquiry. While submissions to AJPPS are expected from worldwide scientists and practitioners irrespective of NAPPSA affiliation, we hope that each volume will present a selection of papers of interest to a broad cross-section of our community as well as the journal’s global audience.

AJPPS is established on the foundation of an outstanding editorial team that includes two editors-in-chief who are recognized scientists and leaders in their fields and who will work together to coordinate all editorial functions of the journal. Up to a dozen professional scientists and practitioners will serve as associate editors covering major subthemes within the journal’s scope. Then, to ensure the journal operates within close reach of its authors and readers, we have enlisted an Editorial Advisory Board comprised of members with expertise that spans the pharmaceutical enterprise. Together, the editorial team represents diversity in expertise, career stage, gender, ethnicity, and nationality.

AJPPS recognizes and embraces the three core pillars of success for a professional scientific journal – rigor, speed, and impact. AJPPS will be a selective journal, accepting for review and publication only those submissions that meet conventional standards of rigor and scholarship. Our peer-review process is designed to deliver thorough and transparent peer review with prioritization for the publication of papers having substantial potential for impact. Regarding manuscript processing times, we aim to continuously rank among the top 10% of open-access journals as the fastest time to publication following manuscript submission (or revision, if necessary). The editorial team will continually work with our publisher, Scientific Scholar, to ensure the broadest possible exposure for articles published in the journal up to, and including, archiving and warehousing in highly secure and well-resourced cloud libraries.

AJPPS is being published as an open-access online-only journal. We chose this format because it allows for lower publication costs and faster processing speeds and it provides for highest accessibility for authors and readers across the world. With this model, manuscripts are received and reviewed at no cost to the authors; after peer review, the authors or their sponsors or institutions pay an article publishing fee which reflects the cost of publishing the article and making it available to a worldwide readership. Because AJPPS is sponsored by a professional association, we expect the publication fees to be lower than fees charged by other journals or publishers of comparable stature or impact.

AJPPS values access, inclusivity, excellence, and integrity. Each and every manuscript received will be handled ethically and with fairness. Editorial decisions about each manuscript will focus on the quality and clarity of the science being communicated, with no preference as to topical area, author, institutional affiliation, or country of residence. Whether as author, reviewer, reader, professional colleague, or research participant, we invite the participation of all segments of the pharmacy and pharmaceutical science community, including academia, research organizations, industry, and government agencies. Your contributions will help shape the success and impact of this interdisciplinary scientific endeavor.


Fulltext Views
503

PDF downloads
74
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections